Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial

BACKGROUND: Antiviral therapies against the novel coronavirus SARS-CoV-2, which has caused a global pandemic of respiratory illness called COVID-19, are still lacking. METHODS: Our study (ClinicalTrials.gov: NCT04252885, named ELACOI), was an exploratory randomized (2:2:1) controlled trial assessing...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yueping, Xie, Zhiwei, Lin, Weiyin, Cai, Weiping, Wen, Chunyan, Guan, Yujuan, Mo, Xiaoneng, Wang, Jian, Wang, Yaping, Peng, Ping, Chen, Xudan, Hong, Wenxin, Xiao, Guangming, Liu, Jinxin, Zhang, Lieguang, Hu, Fengyu, Li, Feng, Zhang, Fuchun, Deng, Xilong, Li, Linghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Clinical Advances
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235585/
https://www.ncbi.nlm.nih.gov/pubmed/32838353
http://dx.doi.org/10.1016/j.medj.2020.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235585/
https://www.ncbi.nlm.nih.gov/pubmed/32838353
http://dx.doi.org/10.1016/j.medj.2020.04.001

Ejemplares similares